Viewing Study NCT01770158


Ignite Creation Date: 2025-12-25 @ 12:22 AM
Ignite Modification Date: 2026-05-13 @ 6:36 PM
Study NCT ID: NCT01770158
Status: TERMINATED
Last Update Posted: 2018-04-09
First Post: 2012-10-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Maintenance Therapy With Histamine Dihydrochloride and Interleukin-2 in Adult Acute Myeloid Leukemia (AML) Patients With Measurable Minimal Residual Disease (MRD)- a Non-interventional Study (NIS)
Sponsor: University of Ulm
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Acute myeloid leukemia (AML) View
None Histamine Dihydrochloride View
None Interleukin-2 View